comparemela.com

Robert Koremans News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Recordati : 28 March 2024 - Directors Report on item 1 on the agenda – Financial statements approval and allocation of profit -March 28, 2024 at 12:40 pm EDT

This is an English courtesy translation of the original documentation prepared in Italian language DIRECTORS REPORTS ON THE PROPOSALS ON THE AGENDA OF THE.

Robert koremansDirector reviewStatutory auditorsFinancial statementsOrdinary general meetingExtraordinary reserveChief executive officer

RECORDATI : APPOINTS MILAN ZDRAVKOVIC AS EXECUTIVE VICE PRESIDENT R&D -October 16, 2023 at 07:53 am EDT

NEWS RELEASE RECORDATI APPOINTS MILAN ZDRAVKOVIC AS EXECUTIVE VICE PRESIDENT R&D Milan, 16th October.

Matteo civitaliRobert koremansRaffaele sabiaGlobal medical officeRecordati rare diseases foundationNovo nordiskItalian stock exchangeResearch developmentHealth economics outcome researchMilan zdravkovicExecutive vice presidentSwedish orphan biovitrumChief medicalMedical affairsChief medical officerHealth economics

Recordati, Zdravkovic vice president R&D and Sabia new CMO

Recordati Spa announced Monday the appointment of Milan Zdravkovic as Executive Vice President of Research & Development. This announcement confirms Recordati s continued commitment to accessible.

Rob koremansGiuseppe fabio ciccomascoloRaffaele sabiaRobert koremansNovo nordiskRecordati rare diseases foundationResearch developmentAlliance news is italian service ltdAlliance newsHealth economics outcome researchAffairs departmentGlobal medical officeMilan zdravkovicExecutive vice presidentSwedish orphan biovitrumChief medical

Recordati Industria Chimica e Farmaceutica S p A (RCDTF) CEO Robert Koremans on Q2 2022 Results - Earnings Call Transcript

Recordati Industria Chimica e Farmaceutica S.p.A. (OTCPK:RCDTF) Q2 2022 Results Conference Call July 28, 2022 10:00 AM ET Company Participants Federica De Medici - Investor Relations &.

Giorgio tavoliniKeyur parekhRob koremansHarry sephtonBruno permuttiIntesa sanpaoloRobert koremansCompany participantsCorporate communicationsGoldman sachsCredit suisseInvestor relations corporate communicationsRecordati industria chimicaConference call julyChorus callFederica de medici

Recordati Industria Chimica e Farmaceutica S p A (RCDTF) CEO Robert Koremans on Q1 2022 Results - Earnings Call Transcript

Recordati Industria Chimica e Farmaceutica S.p.A. (OTCPK:RCDTF) Q1 2022 Results Conference Call May 10, 2022 10:00 AM ET Company Participants Federica De Medici - Investor Relations &.

Rajan sharmaGiorgio tavoliniJo waltonAnna murrayHarry sephtonRobert koremansCompany participantsMinistry of healthCredit suisseDeutsche bankCorporate communications of recordatiEuropean medical agencyInvestor relations corporate communicationsRecordati industria chimicaConference call mayChorus call

vimarsana © 2020. All Rights Reserved.